使用Cobas Bio离心分析仪进行血清载脂蛋白A1和B的免疫比浊测定。
Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.
作者信息
Mount J N, Kearney E M, Rosseneu M, Slavin B M
机构信息
Chemical Pathology and Metabolic Disorders, St Thomas's Hospital, London.
出版信息
J Clin Pathol. 1988 Apr;41(4):471-4. doi: 10.1136/jcp.41.4.471.
Abstract
Immunoturbidimetric assays for measuring the apolipoproteins A1 and B using the Cobas Bio centrifugal analyser are described. The methods were specific, offered good sensitivity (less than 0.05 g/l) and intrabatch variability, with coefficients of variation between 2.4% and 3.5%, and were cost effective. Reference ranges were calculated for a group of civil servants, aged 35 to 55 years.
摘要
本文描述了使用Cobas Bio离心分析仪通过免疫比浊法测定载脂蛋白A1和B的方法。这些方法具有特异性，灵敏度高（低于0.05 g/l），批内变异小，变异系数在2.4%至3.5%之间，且成本效益高。还计算了一组年龄在35至55岁之间的公务员的参考范围。
相似文献
1
Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.使用Cobas Bio离心分析仪进行血清载脂蛋白A1和B的免疫比浊测定。
J Clin Pathol. 1988 Apr;41(4):471-4. doi: 10.1136/jcp.41.4.471.
2
Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas Bio centrifugal analyzer: method validation and reference values.
Clin Biochem. 1994 Aug;27(4):310-5. doi: 10.1016/0009-9120(94)90035-3.
3
[Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia].
Ann Biol Clin (Paris). 1985;43(6):885-90.
4
Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum.
Clin Chem. 1986 Jun;32(6):957-61.
5
Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.
Clin Chem. 1991 May;37(5):742-7.
6
Automated immunoturbidimetric assay of serum apolipoprotein A-II using the Cobas-Bio centrifugal analyser: influence of hyperlipoproteinemia.
Clin Biochem. 1985 Dec;18(6):332-7. doi: 10.1016/s0009-9120(85)80070-9.
7
Measurement of serum Apo A1 and Apo B: comparison of immunoturbidimetric and rate nephelometric techniques.
Clin Chim Acta. 1991 Mar 15;197(2):123-31. doi: 10.1016/0009-8981(91)90274-g.
8
Immunoturbidimetric determination of apolipoproteins A-1 and B in serum.血清中载脂蛋白A-1和B的免疫比浊法测定
Scand J Clin Lab Invest. 1987 Nov;47(7):739-44.
9
Comparison of methods for the measurement of apoproteins A1 and B in serum.
Clin Biochem. 1989 Oct;22(5):339-44. doi: 10.1016/s0009-9120(89)80029-3.
10
Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method.
J Clin Chem Clin Biochem. 1988 Nov;26(11):685-8. doi: 10.1515/cclm.1988.26.11.685.
引用本文的文献
1
Change in lipids before onset of dementia, coronary heart disease, and mortality: A 28-year follow-up Whitehall II prospective cohort study.痴呆、冠心病和死亡发病前的血脂变化：一项为期 28 年的前瞻性队列研究——Whitehall II 研究。
Alzheimers Dement. 2023 Dec;19(12):5518-5530. doi: 10.1002/alz.13140. Epub 2023 May 27.
2
Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.补充 L-精氨酸、地奥司明、曲克芦丁和橙皮苷对糖尿病患者的短期影响：一项初步研究。
Biomed Res Int. 2021 Dec 2;2021:3508281. doi: 10.1155/2021/3508281. eCollection 2021.
3
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.通过人类心血管疾病（HumanCVD）基因芯片鉴定的脂质和载脂蛋白的以基因为中心的关联信号。
Am J Hum Genet. 2009 Nov;85(5):628-42. doi: 10.1016/j.ajhg.2009.10.014.
4
Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.载脂蛋白C3 SstI基因多态性在冠心病风险评估中的作用
Mol Cell Biochem. 2004 Apr;259(1-2):59-66. doi: 10.1023/b:mcbi.0000021345.31556.c9.
5
Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study.动脉粥样硬化血栓形成疾病的风险因素与背痛导致的病假有关吗？怀特霍尔二世研究。
J Epidemiol Community Health. 1999 Apr;53(4):197-203. doi: 10.1136/jech.53.4.197.
6
Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic.血脂门诊中微量白蛋白尿、脂蛋白（a）与冠状动脉疾病的患病率。
J Clin Pathol. 1996 Jan;49(1):19-23. doi: 10.1136/jcp.49.1.19.
7
Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.乙型肝炎病毒的长期感染以及低血胆固醇浓度与肝癌之间的关联。
BMJ. 1993 Apr 3;306(6882):890-4. doi: 10.1136/bmj.306.6882.890.
8
Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.脂蛋白(a)作为普通高胆固醇血症患者心肌梗死的独立危险因素。
J Clin Pathol. 1993 Mar;46(3):267-70. doi: 10.1136/jcp.46.3.267.
9
Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.胰岛素抵抗综合征作为非肥胖男性心脏X综合征的一个特征。
Br Heart J. 1994 Jan;71(1):41-4. doi: 10.1136/hrt.71.1.41.
10
Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.免疫比浊法与洛瑞法测定血浆中极低密度脂蛋白载脂蛋白B-100浓度的比较
J Clin Pathol. 1994 Feb;47(2):176-8. doi: 10.1136/jcp.47.2.176.
本文引用的文献
1
Standardization of immunoassays for the quantitation of plasma Apo B protein.
Anal Biochem. 1981 Sep 1;116(1):204-10. doi: 10.1016/0003-2697(81)90345-6.
2
Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.
Clin Chem. 1981 Jun;27(6):856-9.
3
Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.血浆脂质和载脂蛋白作为血管造影定义的冠状动脉疾病存在及严重程度的鉴别指标。
Atherosclerosis. 1983 Oct;49(1):1-7. doi: 10.1016/0021-9150(83)90002-3.
4
Is the ratio of apo B/apo A-I an early predictor of coronary atherosclerosis?载脂蛋白B/载脂蛋白A-I的比值是冠状动脉粥样硬化的早期预测指标吗？
Atherosclerosis. 1986 Nov;62(2):179-82. doi: 10.1016/0021-9150(86)90065-1.
5
Nephelometry of apolipoprotein B in human serum.
Clin Chem. 1979 Feb;25(2):221-6.
Zotero 插件